KBC Group NV Acquires 16,637 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

KBC Group NV grew its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2,498.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,303 shares of the medical instruments supplier's stock after purchasing an additional 16,637 shares during the period. KBC Group NV owned about 0.07% of ICU Medical worth $2,685,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Hexagon Capital Partners LLC grew its holdings in shares of ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 122 shares during the period. Allworth Financial LP boosted its position in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Venturi Wealth Management LLC grew its position in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock valued at $59,000 after buying an additional 302 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of ICU Medical during the 2nd quarter worth $70,000. Finally, Point72 Hong Kong Ltd purchased a new position in shares of ICU Medical during the 3rd quarter worth $72,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price on the stock in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp lifted their price objective on ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. Finally, StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $199.67.

ICU Medical Price Performance

Shares of NASDAQ:ICUI traded up $2.30 during mid-day trading on Tuesday, reaching $160.99. The stock had a trading volume of 161,233 shares, compared to its average volume of 211,783. The business's 50 day moving average price is $160.86 and its 200 day moving average price is $163.04. ICU Medical, Inc. has a 1 year low of $86.80 and a 1 year high of $196.26. The company has a market cap of $3.94 billion, a P/E ratio of -35.23 and a beta of 0.63. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Insider Transactions at ICU Medical

In other news, Director David C. Greenberg sold 972 shares of the business's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now directly owns 5,037 shares in the company, valued at $796,400.07. The trade was a 16.18 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. Insiders have sold 17,737 shares of company stock valued at $2,879,752 in the last ninety days. Corporate insiders own 6.70% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.